- Home
- MLKN vs RLAY Comparison
MLKN vs RLAY Comparison
Compare MLKN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- RLAY
- Stock Information
- Founded
- MLKN 1905
- RLAY 2015
- Country
- MLKN United States
- RLAY United States
- Employees
- MLKN N/A
- RLAY N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLKN Consumer Discretionary
- RLAY Health Care
- Exchange
- MLKN Nasdaq
- RLAY Nasdaq
- Market Cap
- MLKN 1.2B
- RLAY 1.0B
- IPO Year
- MLKN N/A
- RLAY 2020
- Fundamental
- Price
- MLKN $15.98
- RLAY $7.92
- Analyst Decision
- MLKN
- RLAY Strong Buy
- Analyst Count
- MLKN 0
- RLAY 9
- Target Price
- MLKN N/A
- RLAY $16.00
- AVG Volume (30 Days)
- MLKN 1.2M
- RLAY 2.4M
- Earning Date
- MLKN 12-17-2025
- RLAY 11-06-2025
- Dividend Yield
- MLKN 4.71%
- RLAY N/A
- EPS Growth
- MLKN N/A
- RLAY N/A
- EPS
- MLKN N/A
- RLAY N/A
- Revenue
- MLKN $3,764,100,000.00
- RLAY $8,355,000.00
- Revenue This Year
- MLKN $5.40
- RLAY $27.30
- Revenue Next Year
- MLKN $3.96
- RLAY $7.43
- P/E Ratio
- MLKN N/A
- RLAY N/A
- Revenue Growth
- MLKN 5.37
- RLAY N/A
- 52 Week Low
- MLKN $13.77
- RLAY $1.78
- 52 Week High
- MLKN $25.96
- RLAY $8.36
- Technical
- Relative Strength Index (RSI)
- MLKN 55.72
- RLAY 67.06
- Support Level
- MLKN $13.77
- RLAY $6.28
- Resistance Level
- MLKN $15.53
- RLAY $6.76
- Average True Range (ATR)
- MLKN 0.61
- RLAY 0.53
- MACD
- MLKN 0.24
- RLAY 0.11
- Stochastic Oscillator
- MLKN 96.41
- RLAY 82.16
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).